Luis, just keep following biotechs a few more years and you will be a purist too. Let's just say I have talked to the people at Lidak for 2 years now on a regular basis and I did not once catch them trying to exaggerate something. No misrepresentations that I could detect, and believe me, I tried to find them. My initial reaction to the press releases was because this was the kind of stuff I see all the time in biotech, not clear, and bait and switch. But, if you take the press release at it's word.....................
Let's do a calculation.
Most of the placebo group was 8-10 days,,,Let's say 51% at 8 days
We will arbitrarily say the other 49% was 4.1 days
Average this and you get 6 days for the placebo group, in the worst case.
Meanwhile, we know that Lidakol is 4.1 days, or 2 days better than the placebo minimum.
That makes Lidakol the best drug by a day, minimum. And up to 3 to 4 to 5 days better under the best case.
Maybe, lidak was not being evasive, I just had to figure it out. Does anyone know if the CEO likes riddles? Anyway, I need to check and see if my calculations are reasonable.
By the way, my comment about Lidak dropping on news is because biotechs love to fall on positive news. About 90% of the time as far as I can tell. |
